Matt Hancock confirms coronavirus test rationing list

Coronavirus test rationing sees NO priority for schoolchildren and puts teachers FIFTH on the list – as hospital patients, care home residents and NHS staff get swabs before the public

  • Officials say demand for tests is outstripping supply by up to four times
  • Strain on the system has led to long delays to results and unavailability for some
  • Department of Health says members of the public are last in line to get tests
  • Teachers who feel ill will get priority over public to enable schools to stay open 

Hospital patients, care home residents and NHS staff will be at the front of the queue for coronavirus tests, the Department of Health confirmed today.

As demand for swab tests is now outstripping supply – by up to four times as much, according to Test & Trace chief Dido Harding – health chiefs have confirmed their priorities.

Bottom of the list are members of the public who think they have the virus, while those living in areas known to have high infection rates will be higher up the list. 

And teachers will come below volunteers taking part in surveillance studies, which measure the spread of the disease in the UK.

People across England have complained of tests being unavailable anywhere near their homes and being instructed to travel hundreds of miles to an available centre.

The limited numbers of tests available – currently around 257,000 per day, according to officials – have had to be targeted at areas with worse outbreaks, leaving people living in less-affected areas struggling to get access.

Now, Health Secretary Matt Hancock and his department — who plan to carry out 500,000 tests a day by the end of October — have confirmed how tests are being rationed across the UK.

Care homes are known to have around 100,000 made available to them each day because their residents are the most likely to die if they catch the virus.

And NHS hospitals must be able to test all patients while they are in hospital or being admitted.

Officials in the UK have admitted that demand for coronavirus swab tests is higher than supply and have now set out a priority list outlining how they will be rationed

Officials in the UK have admitted that demand for coronavirus swab tests is higher than supply and have now set out a priority list outlining how they will be rationed

Officials in the UK have admitted that demand for coronavirus swab tests is higher than supply and have now set out a priority list outlining how they will be rationed

In a priority list published today the Department of Health said: ‘While capacity is at a record high, demand has rapidly increased and is currently above these levels.

‘As we look towards winter, we have set out below those who we intend to test, as well as how and why we will test them. 

‘The exact allocation of tests across these key areas is dynamic and may change, as it is based on the latest evidence on risk and demand.’

In ranking order this is how tests will be prioritised:

  1. NHS hospital patients, including all new inpatient admissions 
  2. Care home staff (weekly) and residents (monthly and on admission)
  3. NHS staff
  4. Surveillance studies to collect data, and targeted testing at high-risk environments
  5. Teachers who have symptoms 
  6. Members of the public with symptoms in areas with high infection rates
  7. Members of the public with symptoms in other areas

Mr Hancock said: ‘The testing capacity we have is valuable. And we must together prioritise it for the people who need it the most.’

Testing will also be targeted in outbreak areas and teachers will also be given priority.

Among the wider public, people in areas with high incidence will be given priority.

Speaking in the House of Commons, Mr Hancock said testing capacity was at a record high 253,521 but ‘alongside this record expansion, demand has gone up too’.

He told MPs: ‘We need to prioritise the tests on those who need the most to save lives, protect the most vulnerable and make sure our health and care services and our schools can operate safely.

Health Secretary Matt Hancock

Health Secretary Matt Hancock

Baroness Dido Harding

Baroness Dido Harding

Health Secretary Matt Hancock (left) and Baroness Dido Harding, chief of NHS Test & Trace (right), were last week grilled by MPs over the performance of the Covid-19 testing system

‘Today we’ve published our list of where tests are being prioritised, setting out how we will make sure tests are allocated where they’re needed most.

CARE HOMES WAITING UP TO TWO WEEKS FOR TEST RESULTS

Care homes are having to wait up to 15 days for Covid test results, the Daily Mail revealed today.

Managers say the system is so ‘shambolic’ they fear further fatal outbreaks.

With Health Secretary Matt Hancock warning that a virus ‘tipping point’ is approaching, the care bosses demanded a much quicker turnaround.

The Mail spoke to 19 providers which together run 393 homes. Staff or residents tested positive at a third of the chains over the past fortnight and in most cases results came late.

Nine said they had to throw away tests after couriers did not turn up on time. One had to ditch 250 swabs in a week.

Several providers had to wait as long as 15 days and in some cases heard nothing back from laboratories. Results should be processed within 24 hours but the supposedly ‘world- beating’ system has been overwhelmed.

Nadra Ahmed, who is executive chairman of the National Care Association, said the testing chaos was ‘one of the Government’s greatest failings’.

She added: ‘I can’t believe they didn’t envisage that there would be an increase in demand for tests and results in a timely manner as lockdown was eased.

‘We can’t deal with a postcode lottery at this critical time. As it stands, it is utterly chaotic, shambolic and a disgrace.’

Advertisement

‘First, to support acute clinical care. Second, to support and protect people in care homes. Third, NHS staff including GPs and pharmacists. Fourth, targeted testing for outbreak management and surveillance studies. Fifth, testing for teaching staff with symptoms, so we can keep schools and classes open.

‘And then the general public when they have symptoms, prioritising those in areas of high incidence.’

Shortages of swab tests, which are used to diagnose people with the disease, hit scandalous proportions last week.

People from all over the country complained they were unable to get tested anywhere near home, while queues formed outside testing centres in high-infection areas while laying empty in others.

MPs grilled Matt Hancock in the House of Commons and set upon Test & Trace chief, Dido Harding, to fix the mess.

Lady Harding said nobody was ‘expecting’ to see the ‘really sizeable increase in demand’ for checks. 

Greg Clark, the chairman of the Science and Technology Select Committee, told Lady Harding: ‘Clearly you didn’t prepare enough for the schools coming back and people going back to work.

‘The fact that the end of October was the target date to have this capacity in place, was that because you expected a second wave to be in October? Has it come earlier than expected? Is that the problem?’

Lady Harding replied: ‘I don’t think anybody was expecting to see the really sizeable increase in demand that we have seen over the course of the last few weeks.

‘In none of the modelling was that expected and that is why I said I think we all have to think really hard about how we prioritise the use of these tests, that we are clear you should only get tested if you have the coronavirus symptoms.’

Mr Clark said it was ‘dispiriting’ that the ‘right capacity’ was not put in place despite the planned return of schools and workers to offices – circumstances which he described as ‘entirely predictable’. 

Lady Harding appeared to try to pass the buck for the testing shambles to SAGE as she said the current daily capacity of 240,000 had been put in place ‘based on SAGE modelling for what we should be preparing for for the autumn’. 

She revealed there is a staggering mismatch between the number of people wanting tests and the ability to carry them out as she claimed 27 per cent of people requesting a check have no symptoms. 

She told MPs that she did not have precise numbers for how many people wanted tests. But she said phone calls and website visits suggested it was ‘three to four times the number of tests we have available’. 

VITAMIN D DOES NOT PROTECT AGAINST COVID-19, SAYS MATT HANCOCK 

Vitamin D does not appear to have any impact on reducing the incidence of Covid-19, Health Secretary Matt Hancock told MPs today.

He said: ‘Vitamin D is one of the many things that we looked into to see whether it reduces the incidence or the impact of coronavirus and I’ve seen reports that it does.

‘We therefore put it into a trial and unfortunately the results were that it doesn’t appear to have any impact.

‘So, that is the latest clinical advice which, of course, is always kept under review.’

Mr Hancock’s comments come after an official review conducted by the UK drug regulator, the National Institute for Health and Care Excellence (NICE) reviewed five past studies on the subject to work out if the vitamin could help. 

NICE ruled there is not enough good evidence on the subject to say there is a definite link between vitamin D and the severity of coronavirus.

Health officials in the UK recommend that everyone take supplements in the winter, when there is not enough sunlight for people to produce their own, and that black people consider taking them year-round because they do not produce it as quickly.

Some scientists have suggested one reason darker-skinned people are more likely to die of Covid-19 is that they’re more likely to be vitamin D deficient. 

However, taking extra vitamin D above the recommended amount would not make people any less likely to die of Covid-19, NICE concluded.  

Paul Chrisp, director of the Centre for Guidelines at Nice, said: ‘While there are health benefits associated with vitamin D, our rapid evidence summary did not identify sufficient evidence to support the use of vitamin D supplements for the treatment or prevention of Covid-19.

‘We know that the research on this subject is ongoing, and NICE is continuing to monitor new published evidence.’  

Advertisement

Advertisement

Loading

Leave a Reply

Your email address will not be published. Required fields are marked *

Follow by Email
Pinterest
LinkedIn
Share